Mirum Pharmaceuticals, Inc. - common stock —— 季度资产负债表 (NASDAQ:MIRM) | MetaTrader

展开完整图表

新闻

Why Is Mirum Pharmaceuticals (MIRM) Down 10.1% Since Last Earnings Report?

JPMorgan says large-cap biotech is back as profits and pipelines fuel upside

Nvidia, Amazon, SiTime Among New Names On IBD 50, Stock Spotlight And More

Mirum's Q1 Earnings & Revenues Beat Estimates, 2026 View Raised

Mirum Pharmaceuticals, Inc. (MIRM) Q1 2026 Earnings Call Transcript

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Clinical Results in Primary Sclerosing Cholangitis and Hepatitis Delta - Slideshow (NASDAQ:MIRM) 2026-05-06

Here's What Key Metrics Tell Us About Mirum Pharmaceuticals (MIRM) Q1 Earnings

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Beats Revenue Estimates

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Clinical Results in Primary Sclerosing Cholangitis and Hepatitis Delta Transcript

Amazon Hits All-Time High, Leads 20 Top Performers Onto Best Stock Lists

The $1 Billion-Plus Opportunity That Sent Mirum Pharma Catapulting To A Record

Mirum Pharmaceuticals, Inc. (MIRM) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release